Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
The Indo-MIM IPO allotment process is underway after the public issue received an overwhelming response from investors. The ₹3,812.11-crore IPO was subscribed 72.34 times, while the latest Grey Market Premium (GMP) indicates a potential 39% listing gain over the upper price band of ₹485 per share. Investors who applied for the issue can now begin checking their allotment status through the registrar and stock exchange portals.
Investor demand for the Indo-MIM IPO far exceeded the number of shares available, making it one of the most sought-after public issues of the year. By the close of bidding on July 27, the IPO had been subscribed 72.34 times, reflecting strong confidence from institutional as well as retail investors. (The Economic Times)
The strongest demand came from Qualified Institutional Buyers (QIBs), whose reserved portion was subscribed more than 204 times. Non-Institutional Investors (NIIs), including high-net-worth individuals, also showed robust interest with subscriptions exceeding 50 times, while the retail investor category was subscribed around 6.7 times. (IPO Ji)
To understand what this means, imagine there are only 100 shares available, but investors collectively apply for 7,234 shares. Since demand far exceeds supply, allotment is determined according to SEBI’s allocation rules, meaning many applicants may not receive any shares despite valid applications.
Several factors contributed to the enthusiastic response from investors.
First, Indo-MIM entered the market with a sizeable ₹3,812.11-crore offering, comprising a fresh issue of ₹499.10 crore and an Offer for Sale (OFS) worth ₹3,311.21 crore. The company plans to utilise a significant portion of the fresh issue proceeds to reduce outstanding borrowings, strengthening its balance sheet.
Second, market sentiment was supported by a strong grey market premium throughout the subscription period. The GMP remained close to 39%, suggesting healthy demand ahead of listing, although investors should remember that GMP is an unofficial market indicator and not a guarantee of listing performance.
Finally, institutional participation played a major role. A QIB subscription of over 204 times is often viewed as a sign of confidence from large investors, which can further boost retail sentiment during an IPO.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional Buyers (QIBs) | 204.47x |
| Non-Institutional Investors (NIIs) | 50.65x |
| Retail Individual Investors (RIIs) | 6.67x |
| Employees | 9.44x |
| Overall | 72.34x |
Source: IPO subscription data. (IPO Ji)
The Indo-MIM IPO allotment is now the key focus for applicants, with refunds and share credits scheduled for July 29, followed by the company’s proposed stock market debut on July 30, subject to the successful completion of the issue process.
One of the biggest talking points around the Indo-MIM IPO allotment is its strong Grey Market Premium (GMP). As of July 28, the IPO is commanding a GMP of around ₹190, indicating a potential listing gain of nearly 39% over the upper issue price of ₹485 per share.
The grey market is an unofficial market where IPO shares are traded before they are listed on the stock exchanges. While GMP often reflects investor sentiment, it is not regulated by SEBI and should not be treated as a guarantee of listing-day performance.
Here’s a simple example:
Estimated Listing Gain:
(₹190 ÷ ₹485) × 100 = 39.2%
Remember, GMP changes daily depending on market conditions, demand and overall investor sentiment. A strong GMP increases expectations but cannot predict the actual listing price with certainty.
After an IPO closes, the registrar begins the share allocation process according to SEBI guidelines.
Here’s how it works:
The registrar verifies all applications received through ASBA and UPI to ensure funds were successfully blocked and applications are valid.
Shares are allocated separately across:
If applications exceed the number of available shares—as happened with Indo-MIM—allocation in the retail category is generally carried out through a computerized lottery system.
Once the lottery and allocation process is completed:
Applicants can check their Indo-MIM IPO allotment through multiple official platforms.
This is usually the fastest method once allotment is finalised.
Most stockbrokers and ASBA-enabled banks also display IPO allotment results within their apps or websites.
You can:
If you applied for the Indo-MIM IPO, here’s the expected schedule:

| Event | Expected Date |
|---|---|
| IPO Closes | July 27, 2026 |
| Allotment Finalisation | July 28, 2026 |
| Refunds / Fund Unblocking | July 29, 2026 |
| Shares Credited to Demat | July 29, 2026 |
| Listing on NSE & BSE | July 30, 2026 |
Timeline is subject to completion of the allotment process and exchange approvals.
Whether you receive an allotment or not, there are a few important steps to take after the Indo-MIM IPO allotment results are announced.
Although Indo-MIM has generated strong investor interest, IPO investments carry inherent risks.
Investors should evaluate the company’s financials, business model and valuation instead of relying solely on GMP.
Yes. The Indo-MIM IPO allotment has been finalised on July 28, 2026. Applicants can check their status through the registrar, BSE and NSE websites.
You can check your allotment using your PAN, Application Number or DP/Client ID on the registrar’s website or through the BSE and NSE IPO portals.
The IPO was subscribed 72.34 times overall, with the Qualified Institutional Buyers (QIB) portion receiving the highest demand at over 204 times.
The latest Grey Market Premium is around ₹190, indicating an estimated listing premium of approximately 39% over the upper issue price of ₹485 per share. However, GMP is unofficial and can change at any time.
The Indo-MIM IPO allotment marks the next milestone for one of this year’s most sought-after public issues. With the IPO subscribed 72.34 times and the grey market premium indicating a potential 39% listing gain, investor enthusiasm has remained strong throughout the offering.
However, while the high subscription and robust GMP reflect positive market sentiment, investors should remember that listing-day performance can differ from grey market expectations. Those who receive an allotment should assess their investment objectives before listing, while unsuccessful applicants should monitor refunds and keep an eye on future IPO opportunities.